These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9495809

  • 1. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase.
    Reiners JJ, Lee JY, Clift RE, Dudley DT, Myrand SP.
    Mol Pharmacol; 1998 Mar; 53(3):438-45. PubMed ID: 9495809
    [Abstract] [Full Text] [Related]

  • 2. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002).
    Guo M, Joiakim A, Reiners JJ.
    Biochem Pharmacol; 2000 Sep 01; 60(5):635-42. PubMed ID: 10927021
    [Abstract] [Full Text] [Related]

  • 3. The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptor.
    Joiakim A, Mathieu PA, Palermo C, Gasiewicz TA, Reiners JJ.
    Drug Metab Dispos; 2003 Nov 01; 31(11):1279-82. PubMed ID: 14570754
    [Abstract] [Full Text] [Related]

  • 4. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor beta and mitogen-activated protein kinases.
    Guo M, Joiakim A, Dudley DT, Reiners JJ.
    Biochem Pharmacol; 2001 Dec 01; 62(11):1449-57. PubMed ID: 11728381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation.
    Henry EC, Kende AS, Rucci G, Totleben MJ, Willey JJ, Dertinger SD, Pollenz RS, Jones JP, Gasiewicz TA.
    Mol Pharmacol; 1999 Apr 01; 55(4):716-25. PubMed ID: 10101030
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome.
    Joiakim A, Mathieu PA, Elliott AA, Reiners JJ.
    Mol Pharmacol; 2004 Oct 01; 66(4):936-47. PubMed ID: 15385644
    [Abstract] [Full Text] [Related]

  • 9. The aryl hydrocarbon receptor antagonist, 3'methoxy-4'nitroflavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line.
    Davis JW, Burdick AD, Lauer FT, Burchiel SW.
    Toxicol Appl Pharmacol; 2003 Apr 01; 188(1):42-9. PubMed ID: 12668121
    [Abstract] [Full Text] [Related]

  • 10. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation.
    Chen S, Operaña T, Bonzo J, Nguyen N, Tukey RH.
    J Biol Chem; 2005 Feb 11; 280(6):4350-9. PubMed ID: 15572374
    [Abstract] [Full Text] [Related]

  • 11. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.
    Reiners JJ, Clift R, Mathieu P.
    Carcinogenesis; 1999 Aug 11; 20(8):1561-6. PubMed ID: 10426807
    [Abstract] [Full Text] [Related]

  • 12. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
    Andrieux L, Langouët S, Fautrel A, Ezan F, Krauser JA, Savouret JF, Guengerich FP, Baffet G, Guillouzo A.
    Mol Pharmacol; 2004 Apr 11; 65(4):934-43. PubMed ID: 15044623
    [Abstract] [Full Text] [Related]

  • 13. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
    Monteiro P, Gilot D, Langouet S, Fardel O.
    Drug Metab Dispos; 2008 Dec 11; 36(12):2556-63. PubMed ID: 18755850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.
    Joiakim A, Mathieu PA, Shelp C, Boerner J, Reiners JJ.
    Drug Metab Dispos; 2016 May 11; 44(5):665-71. PubMed ID: 26953171
    [Abstract] [Full Text] [Related]

  • 16. AhR- and ERK-dependent pathways function synergistically to mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation.
    Hanlon PR, Ganem LG, Cho YC, Yamamoto M, Jefcoate CR.
    Toxicol Appl Pharmacol; 2003 May 15; 189(1):11-27. PubMed ID: 12758056
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol.
    Singh SU, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard B, Savouret JF, Tenenbaum HC.
    J Endocrinol; 2000 Oct 15; 167(1):183-95. PubMed ID: 11018766
    [Abstract] [Full Text] [Related]

  • 18. Suppressive effects of flavonoids on dioxin toxicity.
    Ashida H.
    Biofactors; 2000 Oct 15; 12(1-4):201-6. PubMed ID: 11216487
    [Abstract] [Full Text] [Related]

  • 19. A novel 4 S [3H]beta-naphthoflavone-binding protein in liver cytosol of female Sprague-Dawley rats treated with aryl hydrocarbon receptor agonists.
    Brauze D, Malejka-Giganti D.
    Biochem J; 2000 May 01; 347 Pt 3(Pt 3):787-95. PubMed ID: 10769184
    [Abstract] [Full Text] [Related]

  • 20. 3',4'-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells.
    Lee JE, Safe S.
    Toxicol Sci; 2000 Dec 01; 58(2):235-42. PubMed ID: 11099636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.